Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: A reanalysis of a randomized, double-blind study

Journal of Affective Disorders

Volumn 126, Issue 3, 2010, Pages 453-457

  Pilhatsch, Maximilian ^a   Wolf, Roland ^b   Winter, Christine ^a   Lewitzka, Ute ^a   Bauer, Michael ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Advanced Medical Services   (Germany)

Author keywords

Amitriptyline; Bipolar disorder; Depression; Lithium; Maintenance treatment; Paroxetine

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; DIAZEPAM; LITHIUM; PAROXETINE;

ADD ON THERAPY; ADULT; AGITATION; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; INSOMNIA; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; MOTOR ACTIVITY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SIDE EFFECT; SOMNOLENCE; SUICIDE; SUICIDE ATTEMPT; SWEATING; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; VOMITING; XEROSTOMIA;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PAROXETINE; RECURRENCE;

EID: 77957349180     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.04.025     Document Type: Article

References (31)

1. I.M. Anderson Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability Journal of Affective Disorders 58 2000 19 36
2. J. Angst, A. Gamma, V. Ajdacic, D. Eich, W. Rossler, and K.R. Merikangas The bipolar spectrum: epidemiology and clinical perspectives Bipolar Disorders 7 2005 18
3. Balance investigators and collaborators Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial Lancet 375 9712 2009 385 395
4. M. Bauer, R. Zaninelli, B. Muller-Oerlinghausen, and W. Meister Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study Journal of Clinical Psychopharmacology 19 1999 164 171
5. M. Bauer, T. Bschor, A. Pfennig, P.C. Whybrow, J. Angst, M. Versiani, and H.J. Moller World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care World Journal of Biological Psychiatry 8 2007 67 104
6. A. Bocchetta, F. Bernardi, C. Burrai, M. Pedditzi, and M. DelZompo A double-blind-study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives Acta Psychiatrica Scandinavica 88 1993 434 439
7. P.E. Christiansen, K. Behnke, C.H. Black, J.K. Ohrstrom, H. BorkRasmussen, and J. Nilsson Paroxetine and amitriptyline in the treatment of depression in general practice Acta Psychiatrica Scandinavica 93 1996 158 163
8. A. Cipriani, H. Pretty, K. Hawton, and J.R. Geddes Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials American Journal of Psychiatry 162 2005 1805 1819
9. Geddes Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials American Journal of Psychiatry 161 2004 1517 vol 161, pg 217, 2004
10. H. Grunze, S. Kasper, G. Goodwin, C. Bowden, D. Baldwin, R. Licht, E. Vieta, and H.J. Möller The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part I: treatment of bipolar depression World Journal Biological Psychiatry 3 2002 115 124
11. H. Grunze, S. Kasper, G. Goodwin, C. Bowden, and H.J. Moller The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment World Journal of Biological Psychiatry 5 2004 120 135
12. L.L. Judd, H.S. Akiskal, P.J. Schettler, J. Endicott, J. Maser, D.A. Solomon, A.C. Leon, J.A. Rice, and M.B. Keller The long-term natural history of the weekly symptomatic status of bipolar I disorder Archives of General Psychiatry 59 2002 530 537
13. C.L.E. Katona Lithium augmentation in refractory depression Psychiatric Developments 6 1988 153 171
14. P.E. Keck Evaluation and management of breakthrough depressive episodes Journal of Clinical Psychiatry 65 2004 11 15
15. T.A. Ketter Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder Journal of Clinical Psychiatry 69 2008 9 15
16. H. Kuhs, and G.A.E. Rudolf A double-blind-study of the comparative antidepressant effect of paroxetine and amitriptyline Acta Psychiatrica Scandinavica 80 1989 145 146
17. H.J. Möller, J. Gallinat, U. Hegerl, M. Arato, Z. Janka, B. Pflug, and H. Bauer Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression Pharmacopsychiatry 31 1998 170 177
18. H.J. Möller, R. Bottlender, H. Grunze, A. Strauss, and J. Wittmann Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? Journal of Affective Disorders 67 2001 141 146
19. B. Müller-Oerlinghausen Lithium long-term treatment - does it act via serotonin Pharmacopsychiatry 18 1985 214 217
20. D.J. Muzina, and J.R. Calabrese Maintenance therapies in bipolar disorder: focus on randomized controlled trials Australian and New Zealand Journal of Psychiatry 39 2005 652 661
21. National Institute of Mental Health DOTES (Dosage Record and Treatment Emergent Symptom) Scale W. Guy, ECDEU assessment manual for psychopharmacology 1976 223 244
22. C.B. Nemeroff, D.L. Evans, L. Gyulai, G.S. Sachs, C.L. Bowden, I.P. Gergel, R. Oakes, and C.D. Pitts Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression American Journal of Psychiatry 158 2001 906 912
23. W. Nolen Quetiapine or lithium vs placebo in the maintenance treatment of bipolar disorder European Neuropsychopharmacology 18 2008 S608
24. Y. Okamoto, N. Motohashi, H. Hayakawa, M. Muraoka, and S. Yamawaki Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex Neuropsychobiology 33 1996 17 20
25. R.M. Post, G.S. Leverich, W.A. Nolen, R.W. Kupka, L.L. Altshuler, M.A. Frye, T. Suppes, S. McElroy, P. Keck, H. Grunze, and J. Walden A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network Bipolar Disorders 5 2003 396 406
26. C.H. Stuppaeck, C. Geretsegger, A.B. Whitworth, H. Schubert, T. Platz, P. Konig, H. Hinterhuber, and W.W. Fleischhacker A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients Journal of Clinical Psychopharmacology 14 1994 241 246
27. Tondo L., G. Vazquez, and R.J. Baldessarini Mania associated with antidepressant treatment: comprehensive meta-analytic review Acta Psychiatrica Scand. 2009
28. M.L.M. van der Loos, P.G.H. Mulder, E.G.T.M. Hartong, M.B.J. Blom, A.C. Vergouwen, H.J.U.E. de Keyzer, P.J.H. Notten, M.L. Luteijn, M.A. Timmermans, and W.A. Nolen Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial Journal of Clinical Psychiatry 70 2009 223 231
29. G. Wegener, Z. Bandpey, I.L. Heiberg, A. Mork, and R. Rosenberg Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat Psychopharmacology 166 2003 188 194
30. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'Donovan, G. MacQueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disorders 11 2009 225 255
31. L.T. Young, R.T. Joffe, J.C. Robb, G.M. MacQueen, M. Marriott, and I. Patelis-Siotis Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression American Journal of Psychiatry 157 2000 124 126